COVID-19 vaccinations in pregnancy: Save mother and baby from COVID-19 pandemic

Insights

Maternal COVID-19 vaccination with Sinopharm or Pfizer/BioNTech generated significant antibodies, with 100% showing vertical transmission to neonates. Antibody levels varied between vaccines and correlated with maternal and fetal factors.

Area of Science:

  • Immunology
  • Vaccinology
  • Perinatology

Background:

  • Maternal vaccination against coronavirus disease 2019 (COVID-19) is crucial for protecting pregnant individuals and neonates.
  • Understanding the immune response and antibody transfer following different COVID-19 vaccines in pregnancy is essential.

Purpose of the Study:

  • To investigate the immune response in pregnant women vaccinated with Sinopharm or Pfizer/BioNTech.
  • To assess the vertical transmission of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) and nucleocapsid (N) proteins from mother to neonate.

Main Methods:

  • Retrospective study of 79 pregnant women vaccinated with Sinopharm or Pfizer/BioNTech.
  • Analysis of anti-N and anti-S antibody levels in paired maternal and umbilical cord blood samples.
  • Correlation of antibody titers and transfer ratios with maternal and fetal factors.

Main Results:

  • All vaccinated pregnant women (100%) generated anti-N and anti-S antibodies.
  • Vertical transmission of antibodies to neonates was observed in all cases.
  • Antibody titers and transfer ratios varied between Sinopharm and Pfizer/BioNTech vaccines.
  • Antibody transfer correlated differently with maternal age, gestational age, latency, and birth weight for each vaccine.

Conclusions:

  • Both Sinopharm and Pfizer/BioNTech vaccines induce significant antibody production in pregnant women.
  • Vertical transmission of protective antibodies to neonates occurs effectively with both vaccine types.
  • Variations in antibody response and transfer exist between different COVID-19 vaccines used during pregnancy.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Vaccinations01:51

Vaccinations

Overview
45.2K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
390
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
419
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
28
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.2K